Skip to main content
About the fund
News & Insights
How to apply
You are here
News & Insights
News & Insights
Portfolio company Astroscreen featured in the Evening Standard
As the UK gears up for a potential election, there are concerns over the role disinformation will play in democracy
October 17, 2019
Quell Therapeutics makes FierceBiotech's 2019 Fierce 15
The list highlights biotech companies whose hard work and cutting-edge research aims to stop disease in its tracks.
September 23, 2019
Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment
Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease...
September 16, 2019
Why we Invested in Quantum Computing start-up Phasecraft
There has been a leap in excitement about quantum computing in the last year thanks to the emergence of a new class of quantum...
September 09, 2019
Achilles Therapeutics raises £100m in Series B
Achilles Therapeutics (“Achilles”), a bio-pharmaceutical company developing personalised cancer immunotherapies, today announces...
September 04, 2019
Orchard Therapeutics Announces Update from POC Study of OTL-203
Orchard Therapeutics announced data from an ongoing proof-of-concept clinical trial evaluating the safety and efficacy of OTL-203...
September 04, 2019
UCL’s Centre for Amyloidosis and Acute Phase Proteins published in the Journal of Medicinal Chemistry
Ground-breaking work by Prof Alessandra Corazza, Prof Sir Mark Pepys, Prof Vittorio Bellotti and colleagues of the Wolfson Drug...
August 27, 2019
Funding academic innovations in advanced therapies: an interview with Simon Goldman
Simon Goldman, Investment Manager for UCLTF, talks to RegMedNet about funding academic innovation
August 01, 2019
Featuring fund highlights from the past year
June 20, 2019
Andrew Elder on healthtech investing
Andrew Elder talks to HS. about his journey from brain surgeon to venture capitalist, the history of healthtech investing and how...
June 18, 2019
UCL Technology Fund Showcase 2019
We would like to thank everyone who attended the 2019 UCL Technology Fund showcase. We hope the event provided some insight on...
June 17, 2019
Hazy wins 'Best Innovation in Data Protection & Privacy'
Hazy wins 'Best Innovation in Data Protection & Privacy' at the 2019 CogX awards.
June 11, 2019
Fund leads £750k investment in Phasecraft
The UCL Technology Fund led a £750k investment into Phasecraft, a pioneering quantum computing company, along with co-investors...
May 29, 2019
UCLTF completes £1m investment into Quell Therapeutics as part of £35m Series A round
UCLTF £1m investment into Quell Therapeutics is part of a £35m Series A round led by Syncona
May 20, 2019
Odin Vision scales up its cancer detection technology
Innovative medtech company Odin Vision is to scale up its pioneering cancer detection technology thanks to an investment round...
April 30, 2019
UCLTF nominated for 'Investment Unit of the Year'
We are delighted to announce that the UCL Technology Fund has been nominated for Investment Unit of the Year by Global University...
April 30, 2019
Astroscreen raises $1m to detect social media manipulation
UK-based start-up Astroscreen has secured $1M in initial funding to progress its pioneering technology which identifies carriers...
April 18, 2019
Data Supports Achievement of Proof-of-Concept Milestone for OTL-300
Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from the trial of OTL-300, for the...
April 16, 2019
Orchard Therapeutics achieves 100% survival rate during trial treatment for ADA-SCID
Orchard Therapeutics, a commercial-stage biopharmaceutical company, presented their two-year follow-up data in 20 patients from...
February 28, 2019
Hazy included in Forbes '15 Machine Learning Companies To Watch In Europe'
Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch.
December 03, 2018
IGEM Therapeutics Announces Final Close of £5m Series A Financing Round
New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE...
November 30, 2018
Orchard Therapeutics announces closing of $225 Million Initial Public Offering
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through...
November 05, 2018
UCL spin-out Hazy adds $1.8 million in seed funding
Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has...
August 01, 2018
UCL Technology Fund investment MeiraGTx raises $75m at IPO
MeiraGTx is its first UCLTF investment to IPO
July 24, 2018
Bloomsbury AI joins the Facebook Team in London
UCL Technology Fund is very proud to have backed Bloomsbury AI and we are delighted that they are joining the Facebook team.
July 04, 2018
Matr raises £4.75 million for AI teaching platform
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL...
June 21, 2018
Freeline secures over £88 million of funding
Freeline Therapeutics announces today that it has raised over £88 million of new capital in a Series B financing round
June 19, 2018
UCL Technology Fund Showcase 2018
The inaugural UCL Technology Fund Showcase, held at Digital Catapult, brought together two years of investing in world-leading...
May 24, 2018
UCL Technology Fund invests in cell therapy company Glialign
The UCL Technology Fund, UK Innovation & Science Seed Fund, alongside support from Innovate UK, have invested in UCL spinout...
May 03, 2018
UCL Technology Fund and ParkWalk invest in adtech machine learning company MediaGamma
The UCL Technology Fund has invested in MediaGamma, the predictive analytics software company, as part of a £2m round in...
February 26, 2018
UCL Technology Fund has approved investment of up to £1m in the development of a gene therapy for p47-CGD
The UCL Technology Fund has approved an investment of up to £1m to support the development of a gene therapy for p47phox-...
April 11, 2017
UCLTF fund drug development platform Canbex for the treatment of multiple sclerosis
Canbex was established to develop the VSN compound series, a drug development platform with potential applications in a wide...
January 16, 2017
Orchard Therapeutics launches with £21-million series A funding round
Orchard Therapeutics has secured £21-million in Series A financing led by F-Prime with UCLTF. Orchard Therapeutics is a...
May 03, 2016
Albion to Manage the UCL Technology Fund
Albion Capital, one of the largest independent venture capital investors in the UK is to manage and administer the newly launched...
January 18, 2016